ACTL7B, a member of the actin family, is involved in cytoskeletal organization and cellular dynamics. The activators listed primarily function by modulating various signaling pathways that can indirectly influence ACTL7B activity. Compounds like Forskolin and IBMX raise intracellular cAMP levels, which in turn can activate protein kinase A (PKA) and other cAMP-dependent pathways. Such pathways are crucial in regulating cytoskeletal rearrangement and actin dynamics, affecting ACTL7B function.
On the other hand, growth factors like EGF, PDGF, TGF-β, Wnt3a, and FGF2 activate their respective receptor tyrosine kinases or signaling cascades, which are integral to various cellular processes including cell proliferation, differentiation, and cytoskeletal organization. These growth factors, by activating their pathways, can indirectly modulate ACTL7B's activity. Similarly, Insulin and IGF-1, through their receptor-mediated signaling, can impact multiple downstream pathways influencing cytoskeletal dynamics. Chemical compounds like PMA, Lithium chloride, and Y-27632 act on specific enzymes like PKC, GSK-3, and ROCK kinase, respectively. These enzymes are key regulators in various signaling pathways, including those related to actin filament formation and organization.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, leading to increased cAMP levels, which can indirectly affect ACTL7B through cAMP-dependent signaling pathways. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
Isobutylmethylxanthine (IBMX) is a non-selective inhibitor of phosphodiesterases, increasing cAMP levels, potentially influencing ACTL7B activity indirectly. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Phorbol 12-myristate 13-acetate (PMA) activates protein kinase C (PKC), which can modulate ACTL7B activity through downstream signaling pathways. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Insulin activates insulin receptor signaling, influencing various downstream pathways that could indirectly modulate ACTL7B activity. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride inhibits GSK-3, a kinase involved in numerous signaling pathways, potentially affecting ACTL7B activity indirectly. | ||||||
Thymosin β4 | 77591-33-4 | sc-396076 sc-396076A | 1 mg 100 mg | $134.00 $7140.00 | ||
Transforming growth factor-beta (TGF-β) activates TGF-β receptor signaling, potentially impacting ACTL7B activity through downstream signaling. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 inhibits ROCK kinase, which is involved in actin cytoskeleton dynamics, potentially affecting ACTL7B activity indirectly by altering cellular dynamics. | ||||||